Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Mohamed R Elnagar

10PUBLICATIONS
59CO-AUTHORS
Molecular targetsPredictive and prognostic markersBiomolecular modelling and designCheminformatics and quantitative structure-activity relationshipsProteins and peptides
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

Sort by Publication Date:
|Jun 22, 2026
Identification of Sulfonamide-Based Thiazolidine-2,4-Dione Derivatives as VEGFR-2 and Tumor-Associated hCA IX Inhibitors With Hypoxia-Targeted Anti-Colorectal Cancer Activity.

|Apr 24, 2026
Discovery of thieno[2,3-<i>d</i>]pyrimidine-based dual Aurora B/VEGFR-2 inhibitors with potent anticancer activity: molecular docking, mechanistic studies, and <i>in vivo</i> validation in a breast cancer model.

|Mar 30, 2026
Thiazole-Semicarbazone Hybrids as Dual-Stage Inhibitors of Leishmania major Growth: Design, Synthesis, and Mechanistic Insights.

Moataz A Shaldam, Haytham O Tawfik, Abdelrahman I Zain-Alabdeen

|Mar 09, 2026
Exploring Pyrazolo[3,4-b]Pyridine and Spiro-Oxindole Hybrids as Selective CDK2 or EGFR Inhibitors for Targeted Cancer Therapy: Design, Synthesis, and Molecular Modeling Insights.

Ahmed K B A W Farouk, Aya A A Al-Tanany, Mohamed R Elnagar

|Dec 31, 2025
Discovery of Novel Piperidinyl-Based Benzoxazole Derivatives as Anticancer Agents Targeting VEGFR-2 and c-Met Kinases.

Wagdy M Eldehna, Zainab M Elsayed, Mohamed R Elnagar

|Jul 20, 2023
Development of new thiazolidine-2,4-dione hybrids as aldose reductase inhibitors endowed with antihyperglycaemic activity: design, synthesis, biological investigations, and <i>in silico</i> insights.

Abdelrahman Hamdi, Muhammad Yaseen, Wafaa A Ewes

Pageof 2

Frequent Collaborators

3 joint publications

Wagdy M Eldehna

3 joint publications

Haytham O Tawfik

2 joint publications

Mohamed R Abdelaal

2 joint publications

Sameh H Soror

2 joint publications

Hesham Haffez

2 joint publications

Abdullah Haikal

2 joint publications

Hamed W El-Shafey

2 joint publications

Abdelrahman Hamdi

2 joint publications

Mohamed M Tawfik

1 joint publications

Mohamed H Kalaba

Frequent Collaborators

3 joint publications

Wagdy M Eldehna

3 joint publications

Haytham O Tawfik

2 joint publications

Mohamed R Abdelaal

2 joint publications

Sameh H Soror